Industry News
Cancer Therapeutics proves concept behind new drug
Cancer Therapeutics has revealed positive preclinical results from a trial of CTx-294886 and that it has produced a new small molecule screening platform. [ + ]
TGA fee hike under fire from industry
Several biotech and pharmaceutical industry associations have banded together to call for the recent TGA fee hike to be wound back. [ + ]
‘God particle’ collides with art and society this Sunday
Last night’s announcement of the discovery of the Higgs boson, or ‘God particle’, will collide with art and society on Sunday 8 July. ‘Colliding Ideas: Art, Society and Physics’ is a free public symposium, to be held at RMIT University in Central Melbourne from noon-5 pm. [ + ]
CERN experiments observe particle consistent with long-sought Higgs boson
At a seminar held at CERN yesterday as a curtain raiser to the year’s major particle physics conference, ICHEP2012 in Melbourne, ATLAS and CMS experiments presented their latest preliminary results in the search for the long-sought Higgs particle. [ + ]
Sirtex sales defy global economic woes
Sirtex Medical (ASX:SRX) recorded strong quarterly and full-year growth for dose sales of its SIR-Spheres targeted radioactive liver cancer treatments. [ + ]
Starpharma accelerates dendrimer program
Starpharma (ASX:SPL) is researching expanding its dendrimer nanotechnology platform to a wide range of drug classes besides its initial focus on chemotherapeutics. [ + ]
QRxPharma may face more trials for MoxDuo
QRxPharma will meet with the FDA in August to discuss whether more trials of MoxDuo IR are required or existing data reanalysed, but CEO John Holaday is confident its application is “more than adequate for approval”. [ + ]
Biomedical and plant sciences the winner with new appointment
Professor Ryan Lister, an expert in the use of advanced DNA sequencing technologies and computational biology to understand how complex biological systems work, has been appointed to The University of Western Australia (UWA). [ + ]
AHG, CSIRO team for stem cell research
Allied Healthcare Group (ASX:AHZ) and the CSIRO have joined forces to develop tissue engineering technologies with the potential to aid tissue repair in the heart. [ + ]
Registrations now open for the R&D Tax Incentive
The new financial year has heralded the launch of the application form for the registration of R&D activities under the new R&D Tax Incentive, which opened on 1 July 2012. [ + ]
Fish learn to cope in high CO2 world
Some coral reef fish may be better prepared to cope with rising CO2 in the world’s oceans - thanks to their parents. Researchers at the ARC Centre of Excellence for Coral Reef Studies (CoECRS) have reported encouraging new findings that some fish may be less vulnerable to high CO2 and an acidifying ocean than previously feared. [ + ]
DNA sequenced for parrot’s ability to parrot
Scientists say they have assembled more completely the string of genetic letters that could control how well parrots learn to imitate their owners and other sounds. [ + ]
Feature: Jill Banfield, extremophile
Geomicrobiology, environmental biogeochemistry, mineralogy, nanogeoscience, metagenomics, microbial community ecology and evolution. These are but some of the research interests of Professor Jill Banfield. [ + ]
CBio to merge with Inverseon
Brisbane's CBio (ASX:CBZ) plans to merge with US-based Inveseon to create new inflammatory disease focused biotech, Invion. [ + ]
pSivida enrols first patient for uveitis trial
pSivida (ASX:PVA) has signed up the first patient for an investigator-sponsored trial of its inserts and ILUVIEN drug in eye disease posterior uveitis. [ + ]